{"id":66341,"date":"2026-05-26T14:54:20","date_gmt":"2026-05-26T06:54:20","guid":{"rendered":"https:\/\/flcube.com\/?p=66341"},"modified":"2026-05-26T14:54:20","modified_gmt":"2026-05-26T06:54:20","slug":"nmpa-issues-comprehensive-guidelines-for-online-prescription-drug-retail-mandating-human-pharmacist-review-and-ai-prescription-blocking","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=66341","title":{"rendered":"NMPA Issues Comprehensive Guidelines for Online Prescription Drug Retail, Mandating Human Pharmacist Review and AI Prescription Blocking"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">China&#8217;s <strong>National Medical Products Administration (NMPA)<\/strong> has released the <strong>&#8220;Compliance Guidelines for Online Retail of Prescription Drugs&#8221;<\/strong>, establishing stringent new requirements to <strong>safeguard public safety<\/strong> in online pharmaceutical transactions and <strong>regulate the rapidly growing digital drug sales market<\/strong>.<\/p>\n\n\n\n<h2 id=\"h-regulatory-framework-overview\" class=\"wp-block-heading\">Regulatory Framework Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Key Requirement<\/th><th>Implementation Details<\/th><\/tr><\/thead><tbody><tr><td><strong>Prescription Review<\/strong><\/td><td>Must be conducted by <strong>licensed pharmacists only<\/strong> \u2013 <strong>AI systems explicitly prohibited<\/strong> from prescription review<\/td><\/tr><tr><td><strong>Workflow Sequence<\/strong><\/td><td>Mandatory &#8220;<strong>diagnosis first, then prescription, then sale<\/strong>&#8221; pathway<\/td><\/tr><tr><td><strong>Prescription Volume Limits<\/strong><\/td><td>Daily prescription review volume per pharmacist must remain within <strong>reasonable ranges<\/strong> to ensure quality<\/td><\/tr><tr><td><strong>Function Separation<\/strong><\/td><td>Clear distinction between <strong>prescribing and dispensing functions<\/strong> with separate service providers<\/td><\/tr><tr><td><strong>Consumer Protection<\/strong><\/td><td><strong>Informed consent required<\/strong> before prescription drug sales; prohibition on <strong>inducing inappropriate purchases<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-technology-amp-compliance-requirements\" class=\"wp-block-heading\">Technology &amp; Compliance Requirements<\/h2>\n\n\n\n<h3 id=\"h-ai-and-fraud-prevention-measures\" class=\"wp-block-heading\">AI and Fraud Prevention Measures<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>AI Prescription Detection:<\/strong> Platforms must implement <strong>technical means to identify and intercept AI-generated prescriptions<\/strong><\/li>\n\n\n\n<li><strong>Fraudulent Prescription Blocking:<\/strong> Systems required to detect and block <strong>fraudulent prescriptions<\/strong> transferred through platforms<\/li>\n\n\n\n<li><strong>Abuse Monitoring:<\/strong> Special focus on <strong>abnormal sales patterns<\/strong> for high-risk drug categories:<\/li>\n\n\n\n<li>Drugs containing substances in <strong>Prohibited List of Stimulants<\/strong><\/li>\n\n\n\n<li><strong>Compound preparations containing psychotropic substances<\/strong><\/li>\n\n\n\n<li>Other drugs with <strong>potential for abuse<\/strong><\/li>\n<\/ul>\n\n\n\n<h3 id=\"h-risk-management-systems\" class=\"wp-block-heading\">Risk Management Systems<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Quality Management System:<\/strong> Mandatory establishment of comprehensive <strong>online drug sales quality management system<\/strong><\/li>\n\n\n\n<li><strong>Risk Monitoring Framework:<\/strong> Encouraged implementation of mechanisms for:<\/li>\n\n\n\n<li>Risk monitoring, analysis, and assessment<\/li>\n\n\n\n<li>Prevention, early warning, and response protocols<\/li>\n\n\n\n<li>Regular inspection and monitoring of platform activities<\/li>\n\n\n\n<li><strong>Purchase Quantity Controls:<\/strong> <strong>Blocking mechanism required<\/strong> \u2013 suspend sales if single or consecutive purchases exceed reasonable quantities<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-market-impact-amp-industry-implications\" class=\"wp-block-heading\">Market Impact &amp; Industry Implications<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Stakeholder<\/th><th>Impact Assessment<\/th><\/tr><\/thead><tbody><tr><td><strong>E-commerce Platforms<\/strong><\/td><td>Significant investment required in compliance systems, pharmacist staffing, and AI detection technology<\/td><\/tr><tr><td><strong>Online Pharmacies<\/strong><\/td><td>Operational costs increase due to human pharmacist requirements and volume limitations<\/td><\/tr><tr><td><strong>Traditional Pharmacies<\/strong><\/td><td>Potential competitive advantage as established compliance infrastructure already in place<\/td><\/tr><tr><td><strong>Telemedicine Providers<\/strong><\/td><td>Must integrate with new workflow requirements and ensure proper diagnosis-prescription separation<\/td><\/tr><tr><td><strong>Consumers<\/strong><\/td><td>Enhanced safety protections but potentially longer wait times for prescription fulfillment<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-competitive-landscape-shift\" class=\"wp-block-heading\">Competitive Landscape Shift<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Market Consolidation Expected:<\/strong> Smaller players may struggle with compliance costs, leading to industry consolidation<\/li>\n\n\n\n<li><strong>Technology Investment Surge:<\/strong> Demand for sophisticated prescription verification and fraud detection systems will drive tech partnerships<\/li>\n\n\n\n<li><strong>Pharmacist Workforce Demand:<\/strong> Increased need for licensed pharmacists creates employment opportunities and potential wage pressure<\/li>\n\n\n\n<li><strong>International Precedent:<\/strong> China&#8217;s approach may influence global regulatory thinking on AI in healthcare decision-making<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-implementation-timeline-amp-enforcement\" class=\"wp-block-heading\">Implementation Timeline &amp; Enforcement<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Phase<\/th><th>Requirements<\/th><\/tr><\/thead><tbody><tr><td><strong>Immediate<\/strong><\/td><td>Platforms must begin implementing quality management systems and prescription review protocols<\/td><\/tr><tr><td><strong>Short-term (2026)<\/strong><\/td><td>Full deployment of AI prescription detection and blocking mechanisms<\/td><\/tr><tr><td><strong>Medium-term (2027)<\/strong><\/td><td>Complete integration of risk monitoring and early warning systems<\/td><\/tr><tr><td><strong>Ongoing<\/strong><\/td><td>Continuous improvement and regular NMPA inspections<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">The guidelines represent a significant escalation in China&#8217;s regulatory oversight of digital health, prioritizing patient safety over convenience and explicitly rejecting AI autonomy in critical healthcare decisions.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward-Looking Statements<\/strong><br>This brief contains forward-looking statements regarding regulatory compliance, market impacts, and industry trends. Actual outcomes may differ due to enforcement priorities, technological developments, market responses, and evolving regulatory interpretations.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>China&#8217;s National Medical Products Administration (NMPA) has released the &#8220;Compliance Guidelines for Online Retail of&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[4],"tags":[99,14],"class_list":["post-66341","post","type-post","status-publish","format-standard","hentry","category-policy-regulatory","tag-ai","tag-nmpa"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>NMPA Issues Comprehensive Guidelines for Online Prescription Drug Retail, Mandating Human Pharmacist Review and AI Prescription Blocking - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China&#039;s National Medical Products Administration (NMPA) has released the &quot;Compliance Guidelines for Online Retail of Prescription Drugs&quot;, establishing stringent new requirements to safeguard public safety in online pharmaceutical transactions and regulate the rapidly growing digital drug sales market.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=66341\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NMPA Issues Comprehensive Guidelines for Online Prescription Drug Retail, Mandating Human Pharmacist Review and AI Prescription Blocking\" \/>\n<meta property=\"og:description\" content=\"China&#039;s National Medical Products Administration (NMPA) has released the &quot;Compliance Guidelines for Online Retail of Prescription Drugs&quot;, establishing stringent new requirements to safeguard public safety in online pharmaceutical transactions and regulate the rapidly growing digital drug sales market.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=66341\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-26T06:54:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66341#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66341\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"NMPA Issues Comprehensive Guidelines for Online Prescription Drug Retail, Mandating Human Pharmacist Review and AI Prescription Blocking\",\"datePublished\":\"2026-05-26T06:54:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66341\"},\"wordCount\":502,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"AI\",\"NMPA\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=66341#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66341\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=66341\",\"name\":\"NMPA Issues Comprehensive Guidelines for Online Prescription Drug Retail, Mandating Human Pharmacist Review and AI Prescription Blocking - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-05-26T06:54:20+00:00\",\"description\":\"China's National Medical Products Administration (NMPA) has released the \\\"Compliance Guidelines for Online Retail of Prescription Drugs\\\", establishing stringent new requirements to safeguard public safety in online pharmaceutical transactions and regulate the rapidly growing digital drug sales market.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66341#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=66341\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66341#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NMPA Issues Comprehensive Guidelines for Online Prescription Drug Retail, Mandating Human Pharmacist Review and AI Prescription Blocking\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"NMPA Issues Comprehensive Guidelines for Online Prescription Drug Retail, Mandating Human Pharmacist Review and AI Prescription Blocking - Insight, China&#039;s Pharmaceutical Industry","description":"China's National Medical Products Administration (NMPA) has released the \"Compliance Guidelines for Online Retail of Prescription Drugs\", establishing stringent new requirements to safeguard public safety in online pharmaceutical transactions and regulate the rapidly growing digital drug sales market.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=66341","og_locale":"en_US","og_type":"article","og_title":"NMPA Issues Comprehensive Guidelines for Online Prescription Drug Retail, Mandating Human Pharmacist Review and AI Prescription Blocking","og_description":"China's National Medical Products Administration (NMPA) has released the \"Compliance Guidelines for Online Retail of Prescription Drugs\", establishing stringent new requirements to safeguard public safety in online pharmaceutical transactions and regulate the rapidly growing digital drug sales market.","og_url":"https:\/\/flcube.com\/?p=66341","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-05-26T06:54:20+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=66341#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=66341"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"NMPA Issues Comprehensive Guidelines for Online Prescription Drug Retail, Mandating Human Pharmacist Review and AI Prescription Blocking","datePublished":"2026-05-26T06:54:20+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=66341"},"wordCount":502,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["AI","NMPA"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=66341#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=66341","url":"https:\/\/flcube.com\/?p=66341","name":"NMPA Issues Comprehensive Guidelines for Online Prescription Drug Retail, Mandating Human Pharmacist Review and AI Prescription Blocking - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-05-26T06:54:20+00:00","description":"China's National Medical Products Administration (NMPA) has released the \"Compliance Guidelines for Online Retail of Prescription Drugs\", establishing stringent new requirements to safeguard public safety in online pharmaceutical transactions and regulate the rapidly growing digital drug sales market.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=66341#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=66341"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=66341#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"NMPA Issues Comprehensive Guidelines for Online Prescription Drug Retail, Mandating Human Pharmacist Review and AI Prescription Blocking"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/66341","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=66341"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/66341\/revisions"}],"predecessor-version":[{"id":66342,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/66341\/revisions\/66342"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=66341"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=66341"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=66341"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}